# Amgen Inc. (AMGN) — Q1-2018 Earnings Results

**Report date:** 2018-04-24 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2018

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.56%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.47 | N/A | +6.61% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on operational performance. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They expressed confidence in ongoing product pipelines.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.56%, likely due to the lack of revenue details and guidance. Investors may be cautious as they await more information on future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2018_